plethora

(redirected from plethoras)
Also found in: Thesaurus, Medical, Legal, Encyclopedia.

pleth·o·ra

 (plĕth′ər-ə)
n.
1. An abundance or excess of something: "[the pitcher's] sinker that clocks in the low nineties ... resulting in a plethora of weakly hit groundballs" (Buzz Bissinger).
2. An excess of blood in the circulatory system or in one organ or area.

[Late Latin plēthōra, from Greek, from plēthein, to be full; see pelə- in Indo-European roots.]

plethora

(ˈplɛθərə)
n
1. superfluity or excess; overabundance
2. (Pathology) pathol obsolete a condition caused by dilation of superficial blood vessels, characterized esp by a reddish face
[C16: via Medieval Latin from Greek plēthōrē fullness, from plēthein to grow full]
plethoric adj
pleˈthorically adv

pleth•o•ra

(ˈplɛθ ər ə)

n.
1. overabundance; excess.
2. a morbid condition due to excess of red corpuscles in the blood or increase in the quantity of blood.
[1535–45; < New Latin < Greek plēthṓra fullness]

Plethora

 an overfullness; repetition or excess.
Examples: plethora of capital, 1835; of Greeks, 1983; of words, 1868; of work.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.plethora - extreme excessplethora - extreme excess; "an embarrassment of riches"
excessiveness, inordinateness, excess - immoderation as a consequence of going beyond sufficient or permitted limits
redundance, redundancy - the attribute of being superfluous and unneeded; "the use of industrial robots created redundancy among workers"

plethora

noun excess, surplus, glut, profusion, surfeit, overabundance, superabundance, superfluity A plethora of books have been written on the subject.
lack, shortage, deficiency, want, scarcity, dearth

plethora

noun
A condition of going or being beyond what is needed, desired, or appropriate:
Translations

plethora

[ˈpleθərə] Nplétora f

plethora

[ˈplɛθərə] npléthore f
a plethora of → une pléthore de

plethora

n (form)Fülle f

plethora

[ˈplɛθərə] npletora, sovrabbondanza

pleth·o·ra

n. plétora, exceso de cualquiera de los líquidos del organismo.
References in periodicals archive ?
17 /PRNewswire/ -- Plethora Solutions Holdings PLC ("Plethora", AIM: PLE), the specialist developer of products for the treatment and management of urological disorders, announces results of a study confirming the role its product, ErecAid(R), as a supplemental first line treatment for erectile dysfunction (ED).
a Shionogi Company, today announced that it has acquired the global rights for PSD502 from Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE).
LONDON, April 1, 2008 /PRNewswire/ -- Plethora Solutions Holdings PLC ("Plethora", AIM: PLE), the developer of specialist products for the treatment and management of urological disorders, today announced that it has entered into a revenue interest financing agreement with Paul Capital Healthcare.
a Shionogi company, and Plethora Solutions Holdings PLC ("Plethora," AIM: PLE), today announced the completion of patient recruitment of the PSD502 registration program for the treatment of premature ejaculation (PE).
Plethora Solutions Holdings PLC, a London-based specialty pharmaceutical company focusing on urological disorders, which is Senetek's partner for its patented erectile dysfunction drug Invicorp(R) in North America, has entered into a revenue interest financing agreement with Paul Capital Healthcare.
a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora"-AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, today announced that the European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met its three co-primary endpoints of Intravaginal Ejaculation Latency Time ('IELT') and Index of Premature Ejaculation ('IPE'; Ejaculatory Control and Sexual Satisfaction domains).
July 9 /PRNewswire-FirstCall/ -- Senetek PLC (BULLETIN BOARD: SNTKY) , a specialty dermatology and skincare company targeting the science of aging, today reported that Plethora Solutions Holdings PLC (AIM: PLE), Senetek's exclusive licensee for its patented erectile dysfunction drug Invicorp(R) in North America, announced on July 2, 2007 that it has secured funding for completion of clinical development and the FDA approval process for Invicorp as detailed in the following press release:
Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, has completed its European Phase III study of PSD502 for the treatment of premature ejaculation (PE) in Europe.
BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug delivery technologies and products, announced today that it has signed an agreement with Plethora Solutions Holdings plc (AIM: PLE), an emerging U.